BioSpace News Archive

Business

Genomma Lab Announces First Quarter 2022 Financial Results Call and Webcast

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), today announced that it will report its First Quarter 2022 results on Wednesday, April 27, 2022 after the Mexican Market (BMV) close.

April 19, 2022
·
2 min read
ChoiceSpine™ Announces Full Market Release of Next Generation Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System

ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces today that it has launched its next-generation Harrier™ SA ALIF System.

April 19, 2022
·
3 min read
Business

Cincinnati Children’s and CTI Announce Name and Managing Director of Joint Venture

Named Current Biologics, as a nod to both the cutting-edge technologies it will help develop and the Ohio River that connects Northern Kentucky and Cincinnati, the company will be led by Robert Preti, PhD.

April 19, 2022
·
5 min read
Deep Brain Stimulation Devices Market Size, Share, Report 2021-2030

The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by 2030 and it is estimated to expand at a CAGR of 5.1% from 2021 to 2030.

April 19, 2022
·
10 min read
Polymerase Chain Reaction (PCR) Market Size, Growth, Trends, Report 2021-2030

The global polymerase chain reaction (PCR) market size is expected to surpass US$ 8.1 Bn by 2030 and is estimated to expand at a CAGR of 6.4% from 2021 to 2030.

April 19, 2022
·
10 min read
Molecular Diagnostics Market to Witness Growth 11.1% By 2030

The global molecular diagnostics market size is expected to surpass around US$ 37.19 Bn by 2030 and it is estimated to expand at a CAGR of 11.1% from 2021 to 2030.

April 19, 2022
·
9 min read
Sleep Apnea Devices Market Size to Surpass Around US$ 14.7 Bn by 2030

The global sleep apnea devices market was valued at US$ 7 Bn in 2020 and is expected to surpass around US$ 14.7 Bn by 2030 with a CAGR of 8.5% from 2021 to 2030.

April 19, 2022
·
9 min read
Oncomatryx Announces a €15 Million Capital Increase to Conduct Clinical Trials Against the Tumor Micro-environment

Following 12 years of pioneering research activities, Oncomatryx is embarking on a new phase in the development of its tumor microenvironment - targeted ADCs.

April 19, 2022
·
2 min read
Optical Preclinical Imaging: The Most Promising Way to Understand Cancer Development

Preclinical imaging is the most vital step in the research of living animals and drug development.

April 19, 2022
·
2 min read
Induced Pluripotent Stem Cells Market Analysis Insights by Latest Trends, Future Growth, Revenue and Demand

Having a sole spotlight on this market guarantees better nature of items, client faithfulness and a laid out conveyance network that can build the accessibility of the item across the globe.

April 19, 2022
·
3 min read